Foundry Innovation & Research 1, Ltd.

Eli Lilly and Company

Fiachra M Sweeney

Hanson S Gifford, Iii

Conor M Hanley

Friedrich Wetterling

Douglas S Sutton

Jessi E Johnson

Stephen Sheridan

John R Britton

Pablo Martin

Mark E Deem

Sean Quinlan

Annette Kent

Shriram Raghunathan

Natasha Clarke

Michael Kelly

Jeffry J Grainger

Peter Tachi Callas

Eoin Patrick Connaughton

Xuance Zhou

Edward McKenna

John William Adams

Brian Wilfley

Toon Diels

Danyang Fan

Miriam Elizabeth Savage

Axel Brisken

Robert Gaul

Stefan Mathieu Alfons Vaes

James Tucker

Andrew Hughes

Peter Callas

Hanson S Gifford Iii

Edward Mckenna

Multistranded conductors adapted to in vivo environments and methods of making same are disclosed, wherein specific configurations, sequences and directions of wire wraps provide implantable multistranded coils with increased cycle life in in vivo environments as well as desirable electrical performance characteristics.

Multistranded conductors adapted to dynamic in vivo environments

Patient fluid management systems, particularly for use in treating patients at various stages of heart failure, are disclosed. Disclosed systems employ vascular dimension monitoring sensors to provide accurate, early, real-time estimation of circulating blood volume as an input metric to the system control, allowing for more accurate modulation of treatment based on the patient's current fluid volume state.

Patient fluid management systems and methods employing integrated fluid status sensing

Display screen or portion thereof with graphical user interface

Wireless, variable inductance and resonant circuit-based vascular monitoring devices, systems, methodologies, and techniques, including specifically configured anchoring structures for same, are disclosed that can be used to assist healthcare professionals in predicting, preventing, and diagnosing various heart-related and other health conditions.

Wireless resonant circuit and variable inductance vascular monitoring implants and anchoring structures therefore

Systems and methods are disclosed that provide for regular, periodic or continuous monitoring of fluid volume based on direct measurement of an inferior vena cava (IVC) physical dimension using a wireless measurement sensor implanted in the IVC. By basing diagnostic decisions and treatments on changes in an IVC physical dimension, information on patient fluid state is available across the entire euvolemic range of fluid states, thus providing earlier warning of hypervolemia or hypovolemia and enabling the modulation of patient treatments to permit more stable long-term fluid management.

Systems and methods for self-directed patient fluid management

An implantable ultrasonic vascular sensor for implantation at a fixed location within a vessel, comprising at least one ultrasound transducer, a transducer drive circuit, and means for wirelessly transmitting ultrasound data from the at least one ultrasound transducer.

Implantable ultrasonic vascular sensor

An implantable sensor for implantation in a vessel, comprising a plurality of electrodes for placement on, in or adjacent a vessel wall, means for providing a drive signal to the electrodes, means for measuring at least one of impedance and capacitance between at least two of the plurality of electrodes, and means for wirelessly communicating data from the sensor and a blood vessel monitoring system comprising same.

Implantable sensors for vascular monitoring

Systems and methods for patient fluid management

An injection device assembly including a housing, a syringe, a drive mechanism and one or more sensing systems are described. The drive mechanism advances the syringe from a storage position to an injection position, and a plunger advances the syringe piston from an initial position to a final position. The status sensing system may include one or more main PCB(s) disposed in an end portion of the injection device assembly's housing. The system may determine various parameters related to an operational status of the injection device, including the location of the devices components, an amount of medication remaining in the device, a temperature of the medication, and whether or not the device is properly contacting the users skin before injection. The system may communicate such determined parameters to an external device via a wireless communication link.

Status sensing systems within an injection device assembly

Wireless, variable inductance and resonant circuit-based vascular monitoring devices, systems, methodologies, and techniques are disclosed that can be used to assist healthcare professionals in predicting, preventing, and diagnosing various heart-related and other health conditions.

Wireless vascular monitoring implants

Growing community of inventors

Dublin, Ireland

Fiachra M Sweeney